RETRACTION of: Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution

MLA

R. Safadi, et al. “RETRACTION of: Amelioration of Hepatic Fibrosis via Beta-Glucosylceramide-Mediated Immune Modulation Is Associated with Altered CD8 and NKT Lymphocyte Distribution.” International Immunology, vol. 23, June 2011, p. 465. EBSCOhost, https://doi.org/10.1093/intimm/dxr054.

APA

R. Safadi, E. Zigmond, O. Pappo, Z. Shalev, & Y. Ilan. (2011). RETRACTION of: Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. International Immunology, 23, 465. https://doi.org/10.1093/intimm/dxr054

Chicago

R. Safadi, E. Zigmond, O. Pappo, Z. Shalev, and Y. Ilan. 2011. “RETRACTION of: Amelioration of Hepatic Fibrosis via Beta-Glucosylceramide-Mediated Immune Modulation Is Associated with Altered CD8 and NKT Lymphocyte Distribution.” International Immunology 23 (June): 465. doi:10.1093/intimm/dxr054.